Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine oral and nasal ED95 for preoperative anxiety in children
ChiCTR2400082312Phase 4Not yet recruiting
- Sponsor
- Xi'an International Medical Center Hospital
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in separation anxiety disorder (SAD) (2 arms), sponsored by Xi'an International Medical Center Hospital. Primary endpoints: Separation Anxiety Score from Parents (PSAS), Mask Induction Acceptance Score and 1 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
separation anxiety disorder (SAD)
Beyond the preview
Go deeper on ChiCTR2400082312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082312.